Proceedings of the National Academy of Sciences · 1976 · 35 citations · 25 references
Life SciencesImmunologyOncologyImmunizationVaccinologyVirologyNucleic Acid VaccinesOncogenic VirusesVaccinationVaccination For Cancer PreventionVaccine-preventable DiseasesViral VaccinesCancer Prevention Through VaccinationOncogenic Virus PreventionRna Tumor VirusesSerotype-specific ImmunitySerotype-specific VaccinationSpontaneous NeoplasmsVaccination-based Cancer PreventionViral Etiology
Immunization of crossbred and F1 mice with combined killed and live Gross leukemia virus AKR type-C viral vaccines suppressed endogeneous N-type AKR virus up to 10,000-fold for significant periods during early life. Since several previous studies in the same and similar crossbred systems revealed direct correlations between low and high levels of type-C virus early in life with low and high incidences of leukemia and other cancers later in life, we believe that prospects for suppression of spontaneous neoplasms are good; however, 8-14 months will be required to achieve the final results. Should cancers be prevented by serotype-specific vaccines, such evidence would provide conclusive proof of endogenous viral etiology.
25
Plaque assay techniques for murine leukemia viruses
Wallace P. Rowe, Wendell E. Pugh, Janet W. Hartley · Virology · 1970 · 1.3K citations